Pricing
Login
Home
Charts
Search
Watchlist
Products

Zim Laboratories Ltd

ZIMLAB
₹147.80-0.69%20 Nov 2026
Reports
Pharma Formulations

Zim Laboratories Ltd

ZIMLAB
₹147.80
-0.69%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹793Cr
Close
Close Price
₹147.80
Industry
Industry
Pharma Formulations
PE
Price To Earnings
278.87
PS
Price To Sales
1.92
Revenue
Revenue
₹414Cr
Rev Gr TTM
Revenue Growth TTM
13.14%
PAT Gr TTM
PAT Growth TTM
-68.59%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
96118829296109728910910594105
Growth YoY
Revenue Growth YoY%
-4.611.821.37.30.0-7.8-12.3-3.712.8-3.231.218.9
Expenses
ExpensesCr
85102748385946883969892100
Operating Profit
Operating ProfitCr
121681012154613725
OPM
OPM%
12.013.39.810.312.013.45.96.511.86.82.65.2
Other Income
Other IncomeCr
121122122612
Interest Expense
Interest ExpenseCr
223333333344
Depreciation
DepreciationCr
445555555557
PBT
PBTCr
7111368-2065-6-3
Tax
TaxCr
230123-1021-2-1
PAT
PATCr
581245-2044-4-2
Growth YoY
PAT Growth YoY%
-27.611.7291.3-42.6-16.3-39.7-307.8-117.710.0-23.4-115.0-388.1
NPM
NPM%
5.06.91.12.64.24.5-2.6-0.54.03.5-4.3-1.9
EPS
EPS₹
1.01.70.20.50.81.0-0.4-0.10.90.8-0.8-0.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
96118829296109728910910594105
Growth YoY
Revenue Growth YoY%
-4.611.821.37.30.0-7.8-12.3-3.712.8-3.231.218.9
Expenses
ExpensesCr
85102748385946883969892100
Operating Profit
Operating ProfitCr
121681012154613725
OPM
OPM%
12.013.39.810.312.013.45.96.511.86.82.65.2
Other Income
Other IncomeCr
121122122612
Interest Expense
Interest ExpenseCr
223333333344
Depreciation
DepreciationCr
445555555557
PBT
PBTCr
7111368-2065-6-3
Tax
TaxCr
230123-1021-2-1
PAT
PATCr
581245-2044-4-2
Growth YoY
PAT Growth YoY%
-27.611.7291.3-42.6-16.3-39.7-307.8-117.710.0-23.4-115.0-388.1
NPM
NPM%
5.06.91.12.64.24.5-2.6-0.54.03.5-4.3-1.9
EPS
EPS₹
1.01.70.20.50.81.0-0.4-0.10.90.8-0.8-0.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
269235273335278307333399367379374414
Growth
Revenue Growth%
0.8-12.516.122.9-17.210.68.519.5-7.83.2-1.213.1
Expenses
ExpensesCr
239204238293255268292347326335344386
Operating Profit
Operating ProfitCr
293135422340415241443028
OPM
OPM%
10.913.412.812.58.112.912.313.011.311.58.06.7
Other Income
Other IncomeCr
-15925-346561111
Interest Expense
Interest ExpenseCr
14109111311867111314
Depreciation
DepreciationCr
9910111416161716202022
PBT
PBTCr
51825220102135241883
Tax
TaxCr
0-167-336116621
PAT
PATCr
5191915371524171262
Growth
PAT Growth%
123.6264.62.8-19.7-78.5122.098.867.9-29.4-29.5-52.0-68.6
NPM
NPM%
1.97.97.04.61.22.44.46.14.73.21.60.5
EPS
EPS₹
6.423.211.93.20.71.53.05.03.52.51.20.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
269235273335278307333399367379374414
Growth
Revenue Growth%
0.8-12.516.122.9-17.210.68.519.5-7.83.2-1.213.1
Expenses
ExpensesCr
239204238293255268292347326335344386
Operating Profit
Operating ProfitCr
293135422340415241443028
OPM
OPM%
10.913.412.812.58.112.912.313.011.311.58.06.7
Other Income
Other IncomeCr
-15925-346561111
Interest Expense
Interest ExpenseCr
14109111311867111314
Depreciation
DepreciationCr
9910111416161716202022
PBT
PBTCr
51825220102135241883
Tax
TaxCr
0-167-336116621
PAT
PATCr
5191915371524171262
Growth
PAT Growth%
123.6264.62.8-19.7-78.5122.098.867.9-29.4-29.5-52.0-68.6
NPM
NPM%
1.97.97.04.61.22.44.46.14.73.21.60.5
EPS
EPS₹
6.423.211.93.20.71.53.05.03.52.51.20.5
Sales CAGR
1 Year-1%
3 Years-2%
5 Years4%
TTM13%
EBITDA CAGR
1 Year-31%
3 Years-17%
5 Years-5%
TTM-23%
PAT CAGR
1 Year-52%
3 Years-38%
5 Years-4%
TTM-69%
Avg. ROCE
1 Year5%
3 Years7%
5 Years10%
TTM4%
CFO / EBITDA
1 Year165%
3 Years93%
5 Years93%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
888161616164949495454
Reserves
ReservesCr
91110129135138145159152190202240239
Current Liabilities
Current LiabilitiesCr
122113141155143142146111159166190182
Non Current Liabilities
Non Current LiabilitiesCr
352820222822203049545374
Total Liabilities
Total LiabilitiesCr
256259298328325325342342447472539548
Current Assets
Current AssetsCr
154154173194182192212191228231276250
Non Current Assets
Non Current AssetsCr
102105125134143133129151219241264298
Total Assets
Total AssetsCr
256259298328325325342342447472539548
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
888161616164949495454
Reserves
ReservesCr
91110129135138145159152190202240239
Current Liabilities
Current LiabilitiesCr
122113141155143142146111159166190182
Non Current Liabilities
Non Current LiabilitiesCr
352820222822203049545374
Total Liabilities
Total LiabilitiesCr
256259298328325325342342447472539548
Current Assets
Current AssetsCr
154154173194182192212191228231276250
Non Current Assets
Non Current AssetsCr
102105125134143133129151219241264298
Total Assets
Total AssetsCr
256259298328325325342342447472539548

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2232373522324938164150
Investing Cash Flow
Investing Cash FlowCr
-12-7-26-21-19-6-15-36-73-40-56
Financing Cash Flow
Financing Cash FlowCr
-10-25-10-15-3-26-33160-928
Net Cash Flow
Net Cash FlowCr
001-110233-823
Free Cash Flow
Free Cash FlowCr
924815325341-57111
CFO To PAT
CFO To PAT%
430.5172.6191.9227.7664.8435.3338.2153.694.4338.3848.5
CFO To EBITDA
CFO To EBITDA%
75.2101.9105.483.196.980.1120.172.239.494.1165.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2232373522324938164150
Investing Cash Flow
Investing Cash FlowCr
-12-7-26-21-19-6-15-36-73-40-56
Financing Cash Flow
Financing Cash FlowCr
-10-25-10-15-3-26-33160-928
Net Cash Flow
Net Cash FlowCr
001-110233-823
Free Cash Flow
Free Cash FlowCr
924815325341-57111
CFO To PAT
CFO To PAT%
430.5172.6191.9227.7664.8435.3338.2153.694.4338.3848.5
CFO To EBITDA
CFO To EBITDA%
75.2101.9105.483.196.980.1120.172.239.494.1165.1

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
20291118260353465391320793
Price To Earnings
Price To Earnings
13.227.416.117.814.427.032.154.9278.9
Price To Sales
Price To Sales
0.60.30.40.80.91.31.00.91.9
Price To Book
Price To Book
1.30.60.71.51.81.91.61.12.7
EV To EBITDA
EV To EBITDA
6.27.24.87.57.813.711.613.433.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.245.044.548.343.539.942.040.541.042.640.740.7
OPM
OPM%
10.913.412.812.58.112.912.313.011.311.58.06.7
NPM
NPM%
1.97.97.04.61.22.44.46.14.73.21.60.5
ROCE
ROCE%
10.014.216.615.35.58.712.815.68.78.05.13.9
ROE
ROE%
5.215.714.010.22.14.58.312.27.24.82.00.7
ROA
ROA%
2.07.26.44.71.02.34.37.23.92.61.10.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
20291118260353465391320793
Price To Earnings
Price To Earnings
13.227.416.117.814.427.032.154.9278.9
Price To Sales
Price To Sales
0.60.30.40.80.91.31.00.91.9
Price To Book
Price To Book
1.30.60.71.51.81.91.61.12.7
EV To EBITDA
EV To EBITDA
6.27.24.87.57.813.711.613.433.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.245.044.548.343.539.942.040.541.042.640.740.7
OPM
OPM%
10.913.412.812.58.112.912.313.011.311.58.06.7
NPM
NPM%
1.97.97.04.61.22.44.46.14.73.21.60.5
ROCE
ROCE%
10.014.216.615.35.58.712.815.68.78.05.13.9
ROE
ROE%
5.215.714.010.22.14.58.312.27.24.82.00.7
ROA
ROA%
2.07.26.44.71.02.34.37.23.92.61.10.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,0791,025874793782660486
Close PriceClose₹320.15511.9094.87147.80223.81285.00406.05
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE52.8310.5817.25278.8732.1629.2620.89
Price To SalesPS1.641.422.541.923.283.993.11
RevenueRevenueCr656722343414239165156
Revenue Growth TTMRev Gr TTM%14.3%14.3%0.7%13.1%13.9%55.2%
PAT Growth TTMPAT Gr TTM%-55.0%21.1%287.7%-68.6%-13.6%39.5%
Market CapitalizationMkt CapCr1,0791,025874793782660486
Close PriceClose₹320.15511.9094.87147.80223.81285.00406.05
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE52.8310.5817.25278.8732.1629.2620.89
Price To SalesPS1.641.422.541.923.283.993.11
RevenueRevenueCr656722343414239165156
Revenue Growth TTMRev Gr TTM%14.3%14.3%0.7%13.1%13.9%55.2%
PAT Growth TTMPAT Gr TTM%-55.0%21.1%287.7%-68.6%-13.6%39.5%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Jun 25
Dec 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 25
Dec 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews